DOD Biotech PCL (BKK:DOD)
Thailand · Delayed Price · Currency is THB 1.640
-0.020 (-1.20%)
May 29, 2026, 4:39 PM ICT
DOD Biotech PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10.51 | 59.59 | -159.33 | 7.19 | -398.33 | 49.79 |
Depreciation & Amortization | 42.63 | 41.94 | 59.57 | 72.26 | 62.87 | 67.04 |
Other Amortization | 1.05 | 1.05 | 1.1 | 1.2 | 1.64 | - |
Loss (Gain) From Sale of Assets | 0.4 | -15.51 | 12.43 | 0.06 | 12.2 | 22.4 |
Asset Writedown & Restructuring Costs | - | - | 149.55 | - | - | 106.64 |
Loss (Gain) From Sale of Investments | 5.56 | -4.99 | -20.95 | -10.05 | 404.64 | -6.14 |
Other Operating Activities | -19.49 | -30.55 | 184.65 | 84.49 | -59.66 | 253.32 |
Change in Accounts Receivable | -37.11 | -24.7 | 89.58 | -43.44 | -124.57 | -66.1 |
Change in Inventory | 10.19 | 27.3 | 14.29 | -8.16 | 48.02 | 54.64 |
Change in Accounts Payable | -3.26 | 9.82 | -40.14 | -8.93 | -7.65 | -116.82 |
Change in Unearned Revenue | 9.24 | -1.16 | -7.4 | 11.73 | - | - |
Change in Other Net Operating Assets | -24.43 | 17.25 | -23.05 | -23.8 | -8.46 | 4.12 |
Operating Cash Flow | -9.3 | 91.31 | 34.8 | 22.8 | -130.71 | 145 |
Operating Cash Flow Growth | - | 162.38% | 52.65% | - | - | -55.00% |
Capital Expenditures | -94.01 | -48.88 | -22.49 | -18.07 | -63.29 | -182.93 |
Sale of Property, Plant & Equipment | 0 | 0.06 | 0.11 | - | 1.42 | 2.35 |
Cash Acquisitions | - | - | - | -71.66 | - | - |
Divestitures | - | - | 4.79 | - | - | - |
Sale (Purchase) of Real Estate | - | - | 215 | - | - | - |
Investment in Securities | -159.63 | -160.14 | - | - | - | 109.08 |
Other Investing Activities | 131.91 | 0.77 | -0.17 | -0.06 | -0.25 | -0.86 |
Investing Cash Flow | -121.74 | -208.19 | 197.24 | -89.79 | -62.12 | -72.36 |
Short-Term Debt Issued | - | - | - | 9 | 71.7 | - |
Long-Term Debt Issued | - | 75.1 | - | - | - | 22.31 |
Total Debt Issued | 75.1 | 75.1 | - | 9 | 71.7 | 22.31 |
Short-Term Debt Repaid | - | -45 | -65.49 | -47.21 | - | -53.39 |
Long-Term Debt Repaid | - | -5.81 | -6.12 | -25.16 | -31.54 | -44.39 |
Total Debt Repaid | -53.22 | -50.81 | -71.6 | -72.36 | -31.54 | -97.78 |
Net Debt Issued (Repaid) | 21.88 | 24.29 | -71.6 | -63.36 | 40.16 | -75.47 |
Issuance of Common Stock | - | - | - | 159.4 | 0 | 20.51 |
Other Financing Activities | -1.28 | -1.28 | -5.34 | 8.68 | 21.26 | 1 |
Financing Cash Flow | 20.6 | 23.02 | -76.94 | 104.72 | 61.42 | -53.96 |
Net Cash Flow | -110.43 | -93.86 | 155.1 | 37.72 | -131.41 | 18.68 |
Free Cash Flow | -103.31 | 42.43 | 12.31 | 4.72 | -194 | -37.93 |
Free Cash Flow Growth | - | 244.72% | 160.59% | - | - | - |
Free Cash Flow Margin | -18.11% | 6.83% | 1.86% | 0.68% | -35.38% | -3.72% |
Free Cash Flow Per Share | -0.23 | 0.09 | 0.03 | 0.01 | -0.47 | -0.09 |
Cash Interest Paid | 2.72 | 2.72 | 0.2 | 5.34 | 4.27 | 4.74 |
Cash Income Tax Paid | 4.85 | 4.85 | 26.4 | 4.74 | 3.35 | 43.85 |
Levered Free Cash Flow | -162.93 | -14.17 | 108.19 | 4.28 | 271.63 | -2.39 |
Unlevered Free Cash Flow | -160.88 | -12.38 | 110.52 | 7.6 | 276.07 | 1.8 |
Change in Working Capital | -45.37 | 28.5 | 33.28 | -72.6 | -92.66 | -124.15 |